2-(4-aminopiperidin-1-yl)-N-[[2-[3-(diethylamino)pyrazol-1-yl]phenyl]methyl]-9-propan-2-ylpurin-6-amine
C27H38N10 — CID 175875399
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-aminopiperidin-1-yl)-N-[[2-[3-(diethylamino)pyrazol-1-yl]phenyl]methyl]-9-propan-2-ylpurin-6-amine
2-(4-aminopiperidin-1-yl)-N-[[2-[3-(diethylamino)pyrazol-1-yl]phenyl]methyl]-9-propan-2-ylpurin-6-amine (PubChem CID 175875399) has the molecular formula C27H38N10 and a molecular weight of 502.67 g/mol. Its IUPAC name is 2-(4-aminopiperidin-1-yl)-N-[[2-[3-(diethylamino)pyrazol-1-yl]phenyl]methyl]-9-propan-2-ylpurin-6-amine.
Molecular Properties
| Compound Name | 2-(4-aminopiperidin-1-yl)-N-[[2-[3-(diethylamino)pyrazol-1-yl]phenyl]methyl]-9-propan-2-ylpurin-6-amine |
|---|---|
| PubChem CID | 175875399 |
| Molecular Formula | C27H38N10 |
| Molecular Weight | 502.67 g/mol |
| Exact Mass | 502.33 |
| IUPAC Name | 2-(4-aminopiperidin-1-yl)-N-[[2-[3-(diethylamino)pyrazol-1-yl]phenyl]methyl]-9-propan-2-ylpurin-6-amine |
| SMILES | CCN(CC)c1ccn(-c2ccccc2CNc2nc(N3CCC(N)CC3)nc3c2ncn3C(C)C)n1 |
| InChI | InChI=1S/C27H38N10/c1-5-34(6-2)23-13-16-37(33-23)22-10-8-7-9-20(22)17-29-25-24-26(36(18-30-24)19(3)4)32-27(31-25)35-14-11-21(28)12-15-35/h7-10,13,16,18-19,21H,5-6,11-12,14-15,17,28H2,1-4H3,(H,29,31,32) |
| InChIKey | SNSATDOHXKCDBL-UHFFFAOYSA-N |
| XLogP | 3.98 |
| TPSA | 105.95 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.67 |
| LogP ≤ 5 | 3.98 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175875399 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.